Disclosed are an anticancer prodrug nucleoside cyclic phosphate compound based on liver-specific delivery (LSD) technology and the use thereof, in particular, provided are a compound of formula (I) and an isomer, a pharmaceutically acceptable salt, a hydrate, a solvate and a corresponding pharmaceutical composition thereof, and the use of the compound alone or in combination with other anticancer drugs against cancer, especially in treating hepatic carcinoma (HCC).本發明提供基於肝臟特異性遞送技術 (肝遞送)(Liver Specific Delivery(LSD))的抗癌前體藥物核苷環磷酸酯化合物及應用，具體地，本發明提供了式I化合物及其異構體、可藥用鹽、水合物、溶劑化物，以及相應的藥物組合物。本發明還提供了本發明化合物單獨或與其它抗癌藥物聯合在抗癌中的應用，特別是在治療肝癌(HCC)中的應用。
